Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label, Randomized, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of Budesonide Novolizer Dry Powder Inhaler Compared With Budesonide Turbuhaler Dry Powder Inhaler in Chinese Mild to Moderate Asthma Patients

NCT01269437 is registered in ClinicalTrials.gov with NovaMed Pharmaceuticals Inc. as lead sponsor.

NCT NCT01269437
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01269437 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label, Randomized, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of Budesonide Novolizer Dry Powder Inhaler Compared With Budesonide Turbuhaler Dry Powder Inhaler in Chinese Mild to Moderate Asthma Patients
Lead sponsor
NovaMed Pharmaceuticals Inc.
Phase
Phase 2/3
Overall status
Unknown status
Start date
December 31, 2010
Completion date
October 31, 2011
Enrollment
332 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

asthma